These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 1329996)
1. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 U.S. case-control studies. VI. Nonepithelial cancers among adults. Collaborative Ovarian Cancer Group. Horn-Ross PL; Whittemore AS; Harris R; Itnyre J Epidemiology; 1992 Nov; 3(6):490-5. PubMed ID: 1329996 [TBL] [Abstract][Full Text] [Related]
2. The association of reproductive factors with risk of non-epithelial ovarian cancer and comparison with serous ovarian cancer. Hemmingsen CH; Kjaer SK; Bennetsen AKK; Dehlendorff C; Baandrup L Gynecol Oncol; 2021 Aug; 162(2):469-474. PubMed ID: 34016454 [TBL] [Abstract][Full Text] [Related]
3. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use. Wu ML; Whittemore AS; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M; Mohle-Boetani J Am J Epidemiol; 1988 Dec; 128(6):1216-27. PubMed ID: 3195563 [TBL] [Abstract][Full Text] [Related]
4. Characteristics relating to ovarian cancer risk: collaborative analysis of seven U.S. case-control studies. Epithelial ovarian cancer in black women. Collaborative Ovarian Cancer Group. John EM; Whittemore AS; Harris R; Itnyre J J Natl Cancer Inst; 1993 Jan; 85(2):142-7. PubMed ID: 8418303 [TBL] [Abstract][Full Text] [Related]
5. Risk factors for epithelial ovarian tumours of borderline malignancy. Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425 [TBL] [Abstract][Full Text] [Related]
7. The reduction in risk of ovarian cancer associated with oral-contraceptive use. Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development N Engl J Med; 1987 Mar; 316(11):650-5. PubMed ID: 3821795 [TBL] [Abstract][Full Text] [Related]
8. Hormonal and reproductive factors and the risk of ovarian cancer. Koushik A; Grundy A; Abrahamowicz M; Arseneau J; Gilbert L; Gotlieb WH; Lacaille J; Mes-Masson AM; Parent MÉ; Provencher DM; Richardson L; Siemiatycki J Cancer Causes Control; 2017 May; 28(5):393-403. PubMed ID: 28102526 [TBL] [Abstract][Full Text] [Related]
9. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. Risch HA; Marrett LD; Jain M; Howe GR Am J Epidemiol; 1996 Aug; 144(4):363-72. PubMed ID: 8712193 [TBL] [Abstract][Full Text] [Related]
10. Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III. Oral contraceptive use. Franceschi S; Parazzini F; Negri E; Booth M; La Vecchia C; Beral V; Tzonou A; Trichopoulos D Int J Cancer; 1991 Aug; 49(1):61-5. PubMed ID: 1874572 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for epithelial ovarian cancer in Beijing, China. Chen Y; Wu PC; Lang JH; Ge WJ; Hartge P; Brinton LA Int J Epidemiol; 1992 Feb; 21(1):23-9. PubMed ID: 1544753 [TBL] [Abstract][Full Text] [Related]
12. Cigarette smoking and the risk of epithelial ovarian cancer. Franks AL; Lee NC; Kendrick JS; Rubin GL; Layde PM Am J Epidemiol; 1987 Jul; 126(1):112-7. PubMed ID: 3591776 [TBL] [Abstract][Full Text] [Related]
13. Factors affecting the association of oral contraceptives and ovarian cancer. Cramer DW; Hutchison GB; Welch WR; Scully RE; Knapp RC N Engl J Med; 1982 Oct; 307(17):1047-51. PubMed ID: 7121514 [TBL] [Abstract][Full Text] [Related]
14. Events of reproductive life and the incidence of epithelial ovarian cancer. Risch HA; Weiss NS; Lyon JL; Daling JR; Liff JM Am J Epidemiol; 1983 Feb; 117(2):128-39. PubMed ID: 6681935 [TBL] [Abstract][Full Text] [Related]
15. Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer. Gwinn ML; Lee NC; Rhodes PH; Layde PM; Rubin GL J Clin Epidemiol; 1990; 43(6):559-68. PubMed ID: 2348208 [TBL] [Abstract][Full Text] [Related]
16. Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness. Poole EM; Merritt MA; Jordan SJ; Yang HP; Hankinson SE; Park Y; Rosner B; Webb PM; Cramer DW; Wentzensen N; Terry KL; Tworoger SS Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):429-37. PubMed ID: 23307531 [TBL] [Abstract][Full Text] [Related]
17. The risk of epithelial ovarian cancer in short-term users of oral contraceptives. Gross TP; Schlesselman JJ; Stadel BV; Yu W; Lee NC Am J Epidemiol; 1992 Jul; 136(1):46-53. PubMed ID: 1415131 [TBL] [Abstract][Full Text] [Related]
18. Declining ovarian cancer rates in U.S. women in relation to parity and oral contraceptive use. Gnagy S; Ming EE; Devesa SS; Hartge P; Whittemore AS Epidemiology; 2000 Mar; 11(2):102-5. PubMed ID: 11021604 [TBL] [Abstract][Full Text] [Related]
19. Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes. Sköld C; Koliadi A; Enblad G; Stålberg K; Glimelius I Int J Cancer; 2022 Mar; 150(5):773-781. PubMed ID: 34648676 [TBL] [Abstract][Full Text] [Related]
20. Population-based case-control study of ovarian cancer in Shanghai. Shu XO; Brinton LA; Gao YT; Yuan JM Cancer Res; 1989 Jul; 49(13):3670-4. PubMed ID: 2731180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]